Androgen receptor (AR) in cardiovascular diseases

  1. Chawnshang Chang1,2⇑
  1. 1George Whipple Lab for Cancer Research, Departments of Pathology, Urology, and The Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
  2. 2Sex Hormone Research Center, China Medical University/Hospital, Taichung, Taiwan
  3. 3Department of Medicine, Case Cardiovascular Institute Research Institute, Case Western Reserve University, Cleveland, OH, USA
  1. Correspondence should be addressed to C Chang; Email: chang{at}urmc.rochester.edu
  1. View larger version:
    Figure 1

    The impact of knocking out cell-specific AR on the development and progression of CVDs. A full colour version of this figure is available at http://dx.doi.org/10.1530/JOE-15-0518.

| Table of Contents

This Article

  1. Published online before print January 14, 2016, doi: 10.1530/JOE-15-0518 J Endocrinol 229 R1-R16
  1. AbstractFree
  2. Figures Only
  3. Full Text
  4. Full Text (PDF)
  5. All Versions of this Article:
    1. JOE-15-0518v1
    2. 229/1/R1 most recent

Article Metrics

  1. Article Usage Statistics

Current Issue

  1. December 2017, 235 (3)
  1. Current Issue
  1. Alert me to new issues of Journal of Endocrinology

Most